Pediatr. pro Praxi, 2006; 3: 143-148

Chronic abdominal pain in children

MUDr. Vladimír Volf Ph.D
Klinika dětí a dorostu, 3. lékařská fakulta UK a FN Královské Vinohrady, Praha

Chronic abdominal pain in children are one of the most common symptoms investigated in gastroenterology service. Etiology of that complaints are different and also different in a specific children´s age. The inflammation bowel disease and malabsorption syndrome includes all states in which there appear disorders in the digestion and absorption of basic nutrients and consequently disease due to a deficienty of those substance.

Keywords: chronic abdominal pain, children, adolescent, diagnosis, radionuclid methods of treatment

Published: July 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Volf V. Chronic abdominal pain in children. Pediatr. praxi. 2006;7(3):143-148.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Boutnik Y, Alain S, Attar A, et al. Bacterial populations contaming the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 1999; 94: 1327-332. Go to original source... Go to PubMed...
    2. De Dombai FT, Buton I, Goligher JC. Recurrence of Crohn´s disease after primary excisional surgery. Gut 2003; 12: 519-27. Go to original source... Go to PubMed...
    3. Escher JC, Amil DJ, Bochanek K, et al. Medical position paper. IBD working group of ESPGHAN - Inflammatory bowel disease in children and adolescents: Recommendations for diagnosis. The Porto criteria. J Pediatr Gastroenterol Nutr 2004; 39: 4: 231-42.
    4. Feagan BG, Sandborn WJ, Baker J, et al. A randomized, double-blind, placebo controlled, multicenter trial of the engineered human antibody to TNF for steroid sparing and maintenance of remission in patients with steroid-dependent Crohn´s disease. Gastroenterology 2000; 118: A 655. Go to original source...
    5. Galperin C, Gerswin E. Immunopathogenesis of gastroeintestinal and hepatobiliary diseases. JAMA 2001; 278: 1946. Go to original source...
    6. Ghosh S, Goldin E, Malchow H, et al. A randomized, double-blind, placebo-controlled, panEuropean study of a recombinant humanised antibody to alpha 4 integrin (Antegren) in moderate to severely active Crohn´s disease. Gastroenterology 2001; 121: A 127-A 128. Go to original source...
    7. Gordon FH, Lai CW, Hamilton MI, et al. A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha 4 integrin in active Crohn´s disease. Gastroenterology 2001; 121: 268-74. Go to original source... Go to PubMed...
    8. Halttunen T, Maki M. Serum IgA from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell diferenciacion. Gastroenterology 1999; 116: 566-70. Go to original source... Go to PubMed...
    9. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn´disease in German and British population. Lancet 2001; 357: 1925-928. Go to original source... Go to PubMed...
    10. Hoffenberg EJ, Rothenberg SS, Bensard D. Outcome after exploratory laparoscopy for unexplained abdominal pain in childhood. Arch Pediatr Adolesc Med1997; 151: 991-93. Go to original source... Go to PubMed...
    11. Hyams JS, Hyman PE. Recurrent abdominal pain and the biopsychosocial model of medical practise. J Pediatr 1998; 133: 473. Go to original source... Go to PubMed...
    12. Kiernan GJ, Cales RH. Emergency medicine clinics of North America. W. B. Saunders Company, Philadelphia, 1999.
    13. Murphy MS. Management of recurrent abdominal pain. Arch Dis Child 2003; 69: 409-512. Go to original source... Go to PubMed...
    14. Paul RI, Christofel KK, Binns HJ, et al. Foreign body ingestions in children: Risk of complication varies with site of initial health care contact. Pediatric Practice Research Group. Pediatrics 2003; 91: 121-36. Go to original source...
    15. Peppercorn MA. Ulcerative colitis and proctitis. Comtemporrary Diagnosis and Management. USA, Pensylvania, Newton: 86-96.
    16. Rutgeerts P, Colombel J, Schreiber S, et al. Treatment of Crohn´s disease: response to Remicade (infliximab) in the ACCENT I trial through week 54. Am J Gastroenterol 2001; 96: S 303. Go to original source...
    17. Sartor RB. Cytokines in intestina inflammation: Pathophysiological and clinical considerations. Gastroenterology 2000; 106: 533. Go to original source... Go to PubMed...
    18. Satsangi J, Morecroft J, Shah NB, Nimro E. Genetics of inflammatory bowel disease: scientific and clinical implications. In: Clinical Gastroenterology 2003; 1: 3-18. Go to original source... Go to PubMed...
    19. Shaffer HA, de Lange EE. Gastrointestinal foreign bodies and strictures: Radiologic interventions. Curr Probl Diagn Radiol 2004; 23: 205-23.
    20. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119: 234-39. Go to original source... Go to PubMed...
    21. Stange EF, Modigliani R, Pena AS, et al. European trial of cyclosporine in chronic active Crohn´s disease: a 12-month study. The European Study Group. Gastroenterology 1995; 109: 774-82. Go to original source... Go to PubMed...
    22. Ševčík P a kol.: Intenzivní medicína, Galén 2000; 10: 156-201.
    23. Vasilauskas EA, Kam LY, Abreu-Martin MT, et al. An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn´s disease. Gastroenterology 2001; 117: 1278-287. Go to original source... Go to PubMed...
    24. Webb WA. Management of foreign bodies of the upper gastrointestinal tract: Update. Gastrointestinal Endosc 1995; 41. 39-47. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.